Global Prophylactic Pediatric Vaccines Sales Market Report Forecast 2017-2021

April 2017 | 102 pages | ID: G82963F44A2EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
ALK - Abello A/S (Denmark)
Altimmune, Inc. (US)
Bavarian Nordic A/S (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech International Limited (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (US)
MedImmune (US)

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 PROPHYLACTIC PEDIATRIC VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Prophylactic Pediatric Vaccines
1.2 Classification of Prophylactic Pediatric Vaccines
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Prophylactic Pediatric Vaccines
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Prophylactic Pediatric Vaccines Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Prophylactic Pediatric Vaccines (2012-2021)
  1.5.1 Global Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2021)
  1.5.2 Global Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON PROPHYLACTIC PEDIATRIC VACCINES INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 PROPHYLACTIC PEDIATRIC VACCINES MANUFACTURING COST ANALYSIS

3.1 Prophylactic Pediatric Vaccines Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Prophylactic Pediatric Vaccines

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Prophylactic Pediatric Vaccines Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Prophylactic Pediatric Vaccines Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL PROPHYLACTIC PEDIATRIC VACCINES COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Prophylactic Pediatric Vaccines Market Competition by Manufacturers
  5.1.1 Global Prophylactic Pediatric Vaccines Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Prophylactic Pediatric Vaccines Revenue and Share by Manufacturers (2012-2017)
5.2 Global Prophylactic Pediatric Vaccines (Volume and Value) by Type
  5.5.1 Global Prophylactic Pediatric Vaccines Sales and Market Share by Type (2012-2017)
  5.5.2 Global Prophylactic Pediatric Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Global Prophylactic Pediatric Vaccines (Volume and Value) by Regions
  5.3.1 Global Prophylactic Pediatric Vaccines Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Prophylactic Pediatric Vaccines Revenue and Market Share by Regions (2012-2017)
5.4 Global Prophylactic Pediatric Vaccines (Volume) by Application

6 UNITED STATES PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 United States Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  6.1.1 United States Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 United States Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 United States Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
6.2 United States Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
6.3 United States Prophylactic Pediatric Vaccines Sales and Market Share by Type
6.4 United States Prophylactic Pediatric Vaccines Sales and Market Share by Application

7 CHINA PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 China Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  7.1.1 China Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 China Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 China Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
7.2 China Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
7.3 China Prophylactic Pediatric Vaccines Sales and Market Share by Type
7.4 China Prophylactic Pediatric Vaccines Sales and Market Share by Application

8 EUROPE PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  8.1.1 Europe Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 Europe Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
8.2 Europe Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
8.3 Europe Prophylactic Pediatric Vaccines Sales and Market Share by Type
8.4 Europe Prophylactic Pediatric Vaccines Sales and Market Share by Application

9 JAPAN PROPHYLACTIC PEDIATRIC VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Prophylactic Pediatric Vaccines Sales and Value (2012-2017)
  9.1.1 Japan Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
  9.1.2 Japan Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
9.2 Japan Prophylactic Pediatric Vaccines Sales and Market Share by Manufacturers
9.3 Japan Prophylactic Pediatric Vaccines Sales and Market Share by Type
9.4 Japan Prophylactic Pediatric Vaccines Sales and Market Share by Application

10 GLOBAL PROPHYLACTIC PEDIATRIC VACCINES MANUFACTURERS ANALYSIS

10.1 ALK - Abello A/S (Denmark)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Altimmune, Inc. (US)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Bavarian Nordic A/S (Denmark)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 BiondVax Pharmaceuticals Ltd. (Israel)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Bharat Biotech International Limited (India)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 GlaxoSmithKline Plc. (UK)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Hualan Biological Engineering Inc. (China)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Janssen Pharmaceuticals, Inc. (US)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 MedImmune (US)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL PROPHYLACTIC PEDIATRIC VACCINES MARKET FORECAST (2017-2021)

13.1 Global Prophylactic Pediatric Vaccines Sales, Revenue Forecast (2017-2021)
13.2 Global Prophylactic Pediatric Vaccines Sales Forecast by Regions (2017-2021)
13.3 Global Prophylactic Pediatric Vaccines Sales Forecast by Type (2017-2021)
13.4 Global Prophylactic Pediatric Vaccines Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prophylactic Pediatric Vaccines
Table Classification of Prophylactic Pediatric Vaccines
Figure Global Sales Market Share of Prophylactic Pediatric Vaccines by Type in 2015
Table Applications of Prophylactic Pediatric Vaccines
Figure Global Sales Market Share of Prophylactic Pediatric Vaccines by Application in 2015
Figure United States Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure China Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure Europe Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure Japan Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Figure Global Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2021)
Figure Global Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2021)
Table Global Prophylactic Pediatric Vaccines Sales of Key Manufacturers (2012-2017)
Table Global Prophylactic Pediatric Vaccines Sales Share by Manufacturers (2012-2017)
Figure 2015 Prophylactic Pediatric Vaccines Sales Share by Manufacturers
Figure 2016 Prophylactic Pediatric Vaccines Sales Share by Manufacturers
Table Global Prophylactic Pediatric Vaccines Revenue by Manufacturers (2012-2017)
Table Global Prophylactic Pediatric Vaccines Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Prophylactic Pediatric Vaccines Revenue Share by Manufacturers
Table 2016 Global Prophylactic Pediatric Vaccines Revenue Share by Manufacturers
Table Global Prophylactic Pediatric Vaccines Sales and Market Share by Type (2012-2017)
Table Global Prophylactic Pediatric Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Prophylactic Pediatric Vaccines by Type (2012-2017)
Figure Global Prophylactic Pediatric Vaccines Sales Growth Rate by Type (2012-2017)
Table Global Prophylactic Pediatric Vaccines Revenue and Market Share by Type (2012-2017)
Table Global Prophylactic Pediatric Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prophylactic Pediatric Vaccines by Type (2012-2017)
Figure Global Prophylactic Pediatric Vaccines Revenue Growth Rate by Type (2012-2017)
Table Global Prophylactic Pediatric Vaccines Sales and Market Share by Regions (2012-2017)
Table Global Prophylactic Pediatric Vaccines Sales Share by Regions (2012-2017)
Figure Sales Market Share of Prophylactic Pediatric Vaccines by Regions (2012-2017)
Figure Global Prophylactic Pediatric Vaccines Sales Growth Rate by Regions (2012-2017)
Table Global Prophylactic Pediatric Vaccines Revenue and Market Share by Regions (2012-2017)
Table Global Prophylactic Pediatric Vaccines Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Prophylactic Pediatric Vaccines by Regions (2012-2017)
Figure Global Prophylactic Pediatric Vaccines Revenue Growth Rate by Regions (2012-2017)
Table Global Prophylactic Pediatric Vaccines Sales and Market Share by Application (2012-2017)
Table Global Prophylactic Pediatric Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Prophylactic Pediatric Vaccines by Application (2012-2017)
Figure Global Prophylactic Pediatric Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure United States Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure United States Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table United States Prophylactic Pediatric Vaccines Sales by Manufacturers (2012-2017)
Table United States Prophylactic Pediatric Vaccines Market Share by Manufacturers (2012-2017)
Table United States Prophylactic Pediatric Vaccines Sales by Type (2012-2017)
Table United States Prophylactic Pediatric Vaccines Market Share by Type (2012-2017)
Table United States Prophylactic Pediatric Vaccines Sales by Application (2012-2017)
Table United States Prophylactic Pediatric Vaccines Market Share by Application (2012-2017)
Figure China Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure China Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure China Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table China Prophylactic Pediatric Vaccines Sales by Manufacturers (2012-2017)
Table China Prophylactic Pediatric Vaccines Market Share by Manufacturers (2012-2017)
Table China Prophylactic Pediatric Vaccines Sales by Type (2012-2017)
Table China Prophylactic Pediatric Vaccines Market Share by Type (2012-2017)
Table China Prophylactic Pediatric Vaccines Sales by Application (2012-2017)
Table China Prophylactic Pediatric Vaccines Market Share by Application (2012-2017)
Figure Europe Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure Europe Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure Europe Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Sales by Manufacturers (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Market Share by Manufacturers (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Sales by Type (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Market Share by Type (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Sales by Application (2012-2017)
Table Europe Prophylactic Pediatric Vaccines Market Share by Application (2012-2017)
Figure Japan Prophylactic Pediatric Vaccines Sales and Growth Rate (2012-2017)
Figure Japan Prophylactic Pediatric Vaccines Revenue and Growth Rate (2012-2017)
Figure Japan Prophylactic Pediatric Vaccines Sales Price Trend (2012-2017)
Table Japan Prophylactic Pediatric Vaccines Sales by Manufacturers (2012-2017)
Table Japan Prophylactic Pediatric Vaccines Market Share by Manufacturers (2012-2017)
Table Japan Prophylactic Pediatric Vaccines Sales by Type (2012-2017)
Table Japan Prophylactic Pediatric Vaccines Market Share by Type (2012-2017)
Table Japan Prophylactic Pediatric Vaccines Sales by Application (2012-2017)
Table Japan Prophylactic Pediatric Vaccines Market Share by Application (2012-2017)
Table ALK - Abello A/S (Denmark) Basic Information List
Table ALK - Abello A/S (Denmark) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure ALK - Abello A/S (Denmark) Prophylactic Pediatric Vaccines Global Market Share (2012-2017)
Table Altimmune, Inc. (US) Basic Information List
Table Altimmune, Inc. (US) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Altimmune, Inc. (US) Prophylactic Pediatric Vaccines Global Market Share (2012-2017)
Table Bavarian Nordic A/S (Denmark) Basic Information List
Table Bavarian Nordic A/S (Denmark) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bavarian Nordic A/S (Denmark) Prophylactic Pediatric Vaccines Global Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information List
Table BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Pediatric Vaccines Global Market Share (2012-2017)
Table Bharat Biotech International Limited (India) Basic Information List
Table Bharat Biotech International Limited (India) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bharat Biotech International Limited (India) Prophylactic Pediatric Vaccines Global Market Share (2012-2017)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc. (UK) Prophylactic Pediatric Vaccines Global Market Share (2012-2017)
Table Hualan Biological Engineering Inc. (China) Basic Information List
Table Hualan Biological Engineering Inc. (China) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hualan Biological Engineering Inc. (China) Prophylactic Pediatric Vaccines Global Market Share (2012-2017)
Table Janssen Pharmaceuticals, Inc. (US) Basic Information List
Table Janssen Pharmaceuticals, Inc. (US) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals, Inc. (US) Prophylactic Pediatric Vaccines Global Market Share (2012-2017)
Table MedImmune (US) Basic Information List
Table MedImmune (US) Prophylactic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure MedImmune (US) Prophylactic Pediatric Vaccines Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Pediatric Vaccines
Figure Manufacturing Process Analysis of Prophylactic Pediatric Vaccines
Figure Prophylactic Pediatric Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Pediatric Vaccines Major Manufacturers in 2015
Table Major Buyers of Prophylactic Pediatric Vaccines
Table Distributors/Traders List
Figure Global Prophylactic Pediatric Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Global Prophylactic Pediatric Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table Global Prophylactic Pediatric Vaccines Sales Forecast by Regions (2017-2021)
Table Global Prophylactic Pediatric Vaccines Sales Forecast by Type (2017-2021)
Table Global Prophylactic Pediatric Vaccines Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

ALK - Abello A/S (Denmark)
Altimmune, Inc. (US)
Bavarian Nordic A/S (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech International Limited (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (US)
MedImmune (US)
Merck & Co., Inc. (US)
Pfizer Inc. (US)
Sanofi Pasteur SA (France)
Serum Institute of India Pvt. Ltd. (India)
Shanghai BravoBio Co., Ltd. (China)
Seqirus (UK)
SK Chemicals Co., Ltd. (Korea)
Takeda Pharmaceutical Company Limited (Japan)
Zydus Cadila (India)